Report cover image

Exosome Diagnostics Inc - Product Pipeline Analysis, 2022 Update

Publisher GlobalData
Published Feb 07, 2023
Length 39 Pages
SKU # GBDT17776296

Description

Summary

Exosome Diagnostics Inc (Exosome Diagnostics) is a provider of diagnostic solutions. The company develops, designs, manufactures and markets biofluid-based molecular diagnostic tests and products for use in personalized medicine. Exosome Diagnostics’ services comprises of miRNA profiling, mRNA profiling, mutation detection, ribonucleic acid (RNA) sequencing (including full RNA seq) and custom assay development services. The company also offers disease detection, diagnosis, treatment and monitoring. Exosome Diagnostics pharma services includes Exosome Enrichment and Exosome Depletion. Its technology is used in the treatment of brain cancer, prostate cancer, and Alzheimer's disease. Exosome Diagnostics is headquartered in Waltham, Massachusetts, the United States.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Exosome Diagnostics Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

39 Pages
Exosome Diagnostics Inc Company Overview
Exosome Diagnostics Inc Company Snapshot
Exosome Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
Exosome Diagnostics Inc – Pipeline Analysis Overview
Exosome Diagnostics Inc - Key Facts
Exosome Diagnostics Inc - Major Products and Services
Exosome Diagnostics Inc Pipeline Products by Development Stage
Exosome Diagnostics Inc Pipeline Products Overview
Biofluid Nucleic Acid Kit - Alzheimer's Disease
Biofluid Nucleic Acid Kit - Alzheimer's Disease Product Overview
Biofluid Nucleic Acid Kit - Cardiovascular Disease
Biofluid Nucleic Acid Kit - Cardiovascular Disease Product Overview
Biofluid Nucleic Acid Kit - Chronic Kidney Disease
Biofluid Nucleic Acid Kit - Chronic Kidney Disease Product Overview
Biofluid Nucleic Acid Kit - Parkinson's Disease
Biofluid Nucleic Acid Kit - Parkinson's Disease Product Overview
Biofluid-Based Molecular Diagnostic Test - Brain Cancer
Biofluid-Based Molecular Diagnostic Test - Brain Cancer Product Overview
BIONIC Liquid Biopsy - Bladder Cancer
BIONIC Liquid Biopsy - Bladder Cancer Product Overview
Diagnostic Assay - Arv7
Diagnostic Assay - Arv7 Product Overview
Diagnostic Assay - BRAF
Diagnostic Assay - BRAF Product Overview
Diagnostic Assay - Breast Cancer Signature
Diagnostic Assay - Breast Cancer Signature Product Overview
Diagnostic Assay - IDH1
Diagnostic Assay - IDH1 Product Overview
Diagnostic Test - Parkinson's Disease
Diagnostic Test - Parkinson's Disease Product Overview
EGFR 29 Mutation Panel
EGFR 29 Mutation Panel Product Overview
ExoTRU Kidney Transplant Rejection Test
ExoTRU Kidney Transplant Rejection Test Product Overview
Midi Lung Cancer Panel
Midi Lung Cancer Panel Product Overview
Next-Generation Solid Tumor Mutation Panel
Next-Generation Solid Tumor Mutation Panel Product Overview
Sjogren Syndrome Assay
Sjogren Syndrome Assay Product Overview
Exosome Diagnostics Inc - Key Competitors
Exosome Diagnostics Inc - Key Employees
Exosome Diagnostics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Exosome Diagnostics Inc, Recent Developments
Oct 10, 2019: Medicare issues final local coverage decision for bio-Techne's ExoDx Prostate(IntelliScore) Test
Jun 17, 2019: FDA grants breakthrough device designation to Bio-Techne's ExoDx Prostate IntelliScore (EPI) Test
Jun 13, 2019: Bio-Techne receives approval to offer The ExoDx Prostate Intelliscore (EPI) test in New York State
Sep 18, 2018: Bio-Techne announces publication of data demonstrating additional clinical validation of its EPI Test in European Urology Journal
Jun 13, 2018: Exosome Diagnostics Receives ISO 13485:2016 Certification
May 22, 2018: Exosome Diagnostics Announces Bladder Cancer Surveillance Panel
May 17, 2018: Exosome Diagnostics’ Second Prospective Validation Study of EPI to be Highlighted at American Urological Association (AUA) Annual Meeting Press Briefing in San Francisco, CA
May 15, 2018: Exosome Diagnostics Presents Breakthrough Data Highlighting Tumor Derived RNA in Biofluids at the International Society for Extracellular Vesicles in Spain
May 09, 2018: Exosome Diagnostics Continues to Expand Coverage Reach for its EPI Test
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Table 1: Exosome Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
Table 2: Exosome Diagnostics Inc Pipeline Products by Equipment Type
Table 3: Exosome Diagnostics Inc Pipeline Products by Indication
Table 4: Exosome Diagnostics Inc, Key Facts
Table 5: Exosome Diagnostics Inc, Major Products and Services
Table 6: Exosome Diagnostics Inc Number of Pipeline Products by Development Stage
Table 7: Exosome Diagnostics Inc Pipeline Products Summary by Development Stage
Table 8: Biofluid Nucleic Acid Kit - Alzheimer's Disease - Product Status
Table 9: Biofluid Nucleic Acid Kit - Alzheimer's Disease - Product Description
Table 10: Biofluid Nucleic Acid Kit - Cardiovascular Disease - Product Status
Table 11: Biofluid Nucleic Acid Kit - Cardiovascular Disease - Product Description
Table 12: Biofluid Nucleic Acid Kit - Chronic Kidney Disease - Product Status
Table 13: Biofluid Nucleic Acid Kit - Chronic Kidney Disease - Product Description
Table 14: Biofluid Nucleic Acid Kit - Parkinson's Disease - Product Status
Table 15: Biofluid Nucleic Acid Kit - Parkinson's Disease - Product Description
Table 16: Biofluid-Based Molecular Diagnostic Test - Brain Cancer - Product Status
Table 17: Biofluid-Based Molecular Diagnostic Test - Brain Cancer - Product Description
Table 18: BIONIC Liquid Biopsy - Bladder Cancer - Product Status
Table 19: BIONIC Liquid Biopsy - Bladder Cancer - Product Description
Table 20: Diagnostic Assay - Arv7 - Product Status
Table 21: Diagnostic Assay - Arv7 - Product Description
Table 22: Diagnostic Assay - BRAF - Product Status
Table 23: Diagnostic Assay - BRAF - Product Description
Table 24: Diagnostic Assay - Breast Cancer Signature - Product Status
Table 25: Diagnostic Assay - Breast Cancer Signature - Product Description
Table 26: Diagnostic Assay - IDH1 - Product Status
Table 27: Diagnostic Assay - IDH1 - Product Description
Table 28: Diagnostic Test - Parkinson's Disease - Product Status
Table 29: Diagnostic Test - Parkinson's Disease - Product Description
Table 30: EGFR 29 Mutation Panel - Product Status
Table 31: EGFR 29 Mutation Panel - Product Description
Table 32: ExoTRU Kidney Transplant Rejection Test - Product Status
Table 33: ExoTRU Kidney Transplant Rejection Test - Product Description
Table 34: Midi Lung Cancer Panel - Product Status
Table 35: Midi Lung Cancer Panel - Product Description
Table 36: Next-Generation Solid Tumor Mutation Panel - Product Status
Table 37: Next-Generation Solid Tumor Mutation Panel - Product Description
Table 38: Sjogren Syndrome Assay - Product Status
Table 39: Sjogren Syndrome Assay - Product Description
Table 40: Exosome Diagnostics Inc, Key Employees
Table 41: Exosome Diagnostics Inc, Subsidiaries
Table 42: Glossary
List of Figures
Figure 1: Exosome Diagnostics Inc Pipeline Products by Equipment Type
Figure 2: Exosome Diagnostics Inc Pipeline Products by Development Stage

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us